Nordson Corporation
NDSN
$334.70
+8.00%
Nordson Corporation is a precision technology company that designs and manufactures dispensing equipment, including pumps, valves, dispensers, applicators, filters, and pelletizers, used across diverse end markets such as packaging, medical, electronics, and industrial applications. As a market leader in precision dispensing, Nordson differentiates itself through its broad portfolio of proprietary technologies and a global service network, operating through three segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. The current investor narrative centers on the company's ability to sustain mid-single-digit organic growth while expanding margins through operational excellence and strategic acquisitions, with recent quarterly results showing robust revenue growth and strong cash generation. The stock has also been a notable outperformer, with a 42% gain over the past year, reflecting confidence in its diversified business model and resilient end-market demand.…
NDSN
Nordson Corporation
$334.70
Investment Opinion: Should I buy NDSN Today?
Rating: Hold. Nordson is a high-quality industrial company with strong margins and growth, but the current valuation leaves limited upside to analyst targets. The average target of $316.86 implies just 2.6% upside, while the stock trades at a 23% premium to the sector P/E. The thesis is supported by accelerating revenue growth (8.5% YoY), superior net margin (17.4% vs 12% industry), and robust free cash flow ($718M). However, the PEG ratio of 5.7 and high debt-to-equity of 0.71 suggest the market is pricing in perfection. This Hold would upgrade to Buy if the P/E compresses below 24x or if revenue growth accelerates above 10%, and downgrade to Sell if growth decelerates below 5% or margins deteriorate. Overall, the stock is fairly valued relative to its history but slightly overvalued versus peers.
Sign up to view all
NDSN 12-Month Price Forecast
The AI assessment leans bullish given Nordson's strong fundamentals and momentum. The company's ability to grow revenue at an accelerating pace while maintaining superior margins is a positive signal. However, the medium confidence reflects the limited analyst coverage and the stock's proximity to its 52-week high, which limits upside. If the company can sustain growth above 8% and expand margins, the stance would strengthen; conversely, any deceleration in growth or margin erosion would warrant a downgrade to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nordson Corporation's 12-month outlook, with a consensus price target around $320.43 and implied upside of -4.3% versus the current price.
Average Target
$320.43
0 analysts
Implied Upside
-4.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$260 - $360
Analyst target range
Analyst coverage is limited, with only 7 analysts providing ratings, and the consensus recommendation is 'none' (mixed). The average target price is $316.86, implying a modest 2.6% upside from the current price of $308.72. The distribution includes 3 Buy/Outperform ratings (DA Davidson, Oppenheimer) and 2 Neutral ratings (BNP Paribas, Baird), with no Sell ratings, indicating a generally positive but cautious sentiment. The low target of $260.00 suggests a potential 15.8% downside, while the high target of $345.00 implies an 11.8% upside, reflecting a wide range of outcomes. The wide spread between low and high targets indicates significant uncertainty about the company's future growth trajectory, possibly due to cyclical exposure and integration risks from acquisitions. Recent ratings actions have been mostly reaffirmations, with no upgrades or downgrades in the past three months, suggesting analysts are comfortable with their current views.
Bulls vs Bears: NDSN Investment Factors
Nordson presents a balanced but slightly bullish case. The company's accelerating revenue growth, superior margins, and strong cash flow provide a solid fundamental foundation, while the premium valuation and modest analyst upside temper enthusiasm. The key tension is whether the market's growth expectations (implied by a 27.1x P/E) are justified by the company's ability to sustain mid-single-digit organic growth and execute acquisitions. If growth continues to accelerate, the stock could re-rate higher; if cyclical headwinds emerge, the premium could compress. Currently, the evidence slightly favors the bull case given the recent momentum and diversified portfolio, but the limited upside to analyst targets warrants caution.
Bullish
- Accelerating revenue growth: Q2 FY2026 revenue grew 8.5% YoY to $740.8M, up from 6.3% YoY in the prior year quarter, indicating improving end-market demand. Sequential growth from $669.5M in Q1 FY2026 and $615.4M in Q1 FY2025 shows a clear upward trajectory.
- Superior profitability vs peers: Net margin of 17.4% and operating margin of 25.9% are well above the industry average net margin of 12%, reflecting strong pricing power and operational efficiency. Gross margin of 55.2% underscores the value-added nature of Nordson's precision dispensing technology.
- Strong free cash flow generation: TTM free cash flow stands at $718.1M, providing ample capacity for dividend payments (yield 1.36%) and strategic acquisitions. This cash generation supports the company's growth strategy and shareholder returns.
- Diversified end-market exposure: Revenue is spread across packaging, medical, electronics, and industrial markets, with all three segments growing in Q2 FY2026. This diversification reduces reliance on any single cycle and supports stable demand.
Bearish
- Premium valuation with limited upside: Trailing P/E of 27.1x is 23% above the sector average of 22x, yet the average analyst target of $316.86 implies only 2.6% upside. The PEG ratio of 5.7 suggests the market is pricing in aggressive growth that may not materialize.
- High debt burden: Debt-to-equity of 0.71 and interest expense of $21.9M in Q2 FY2026 indicate significant leverage, which could constrain financial flexibility if rates stay high. This is a risk for a company with cyclical exposure.
- Modest analyst conviction: With only 7 analysts covering, the consensus is 'none' (mixed), and the wide target range ($260-$345) reflects uncertainty. No recent upgrades or downgrades suggest analysts are waiting for more clarity.
- Potential cyclical sensitivity: As an industrial machinery company, Nordson's results are tied to manufacturing and capital spending cycles. A slowdown in key end markets could pressure revenue growth, especially given the stock's beta of 0.96.
NDSN Technical Analysis
Nordson's stock is in a clear uptrend, with a 1-year price change of +42.1% and currently trading at $308.72, which is 97.8% of its 52-week range (low $211.50, high $315.68). This positioning near the highs indicates strong momentum, but also suggests the stock may be overextended in the short term, as it sits just 2.2% below its 52-week high. The 6-month change of +3.5% is modest, but the 1-year performance significantly outpaces the S&P 500's +20.4%, highlighting Nordson's relative strength.
Beta
0.96
0.96x market volatility
Max Drawdown
-14.4%
Largest decline past year
52-Week Range
$220-$337
Price range past year
Annual Return
+56.8%
Cumulative gain past year
| Period | NDSN Return | S&P 500 |
|---|---|---|
| 1m | +15.4% | +1.9% |
| 3m | +15.5% | +2.3% |
| 6m | +15.3% | +10.6% |
| 1y | +56.8% | +19.5% |
| ytd | +38.9% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NDSN Fundamental Analysis
Nordson's revenue trajectory is solidly growing, with the most recent quarter (Q2 FY2026, ending April 30, 2026) reporting revenue of $740.8 million, up 8.5% year-over-year. This growth is consistent with the prior quarter's revenue of $669.5 million, and the company has shown sequential improvement from $615.4 million in Q1 FY2025. The growth is driven by all three segments, with Industrial Precision Solutions contributing $350.5 million, Medical and Fluid Solutions $212.9 million, and Advanced Technology Solutions $177.5 million, indicating broad-based demand. The revenue growth is accelerating, with the YoY growth rate of 8.5% in Q2 FY2026 up from 6.3% in the prior year quarter, suggesting improving end-market conditions.
Quarterly Revenue
$740847000.0B
2026-04
Revenue YoY Growth
+8.5%
YoY Comparison
Gross Margin
54.5%
Latest Quarter
Free Cash Flow
$718147000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NDSN Overvalued?
For valuation, I selected the trailing P/E ratio as the primary metric because Nordson is profitable, with trailing net income of $117.3 million in the latest quarter. The trailing P/E is 27.1x, while the forward P/E is 24.6x, implying the market expects earnings growth of approximately 10% over the next year. This gap is modest, suggesting the market has reasonable growth expectations. The P/E of 27.1x is above the sector average of 22x, representing a 23% premium, which is justified by Nordson's superior profitability (net margin of 17.4% vs. industry average of 12%) and consistent growth. Historically, Nordson's P/E has ranged from 21.5x to 34.3x over the past two years, and the current 27.1x is near the middle of that range, indicating the stock is fairly valued relative to its own history.
PE
27.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 21x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Nordson carries a debt-to-equity ratio of 0.71, and interest expense of $21.9M in Q2 FY2026, which could pressure earnings if rates rise. The company's net margin of 17.4% is strong, but any margin compression from raw material costs or integration issues could reduce profitability. Free cash flow of $718M provides a cushion, but the high payout ratio of 37% limits dividend growth potential. Revenue concentration in cyclical industrial markets adds volatility, as seen in the -14.4% max drawdown over the past year.
FAQ
The key risks include: 1) Cyclical exposure to industrial and manufacturing end markets, which could lead to revenue declines in a downturn (beta of 0.96). 2) High debt levels (debt-to-equity of 0.71) could strain financial flexibility if interest rates rise. 3) Valuation risk, as the stock trades at a 23% premium to the sector, leaving it vulnerable to multiple compression. 4) Integration risk from acquisitions, which could fail to deliver expected synergies. The most severe risk is a global recession, which could push the stock to $260, a -15.8% downside from current levels.
The 12-month forecast is cautiously optimistic. The base case (50% probability) sees the stock trading around $316.86, the analyst average target, implying 2.6% upside. The bull case (30% probability) targets $330-$345, driven by sustained growth and margin expansion. The bear case (20% probability) sees the stock falling to $260-$280, if a cyclical downturn hits. The most likely scenario is the base case, assuming the company maintains its current growth trajectory. Investors should watch for revenue growth above 8% and margin stability to support the bull case.
NDSN is fairly valued relative to its own history, with a trailing P/E of 27.1x versus a two-year range of 21.5x to 34.3x. However, it is overvalued compared to the sector average P/E of 22x, trading at a 23% premium. The forward P/E of 24.6x implies the market expects ~10% earnings growth, which is reasonable given recent trends. The PEG ratio of 5.7 suggests the stock is expensive relative to its growth rate, but this metric can be misleading for high-quality companies. Overall, the market is pricing in continued mid-single-digit growth and stable margins, which seems justified but leaves little room for error.
NDSN is a good buy for investors seeking a high-quality industrial with strong margins and growth, but the current valuation limits near-term upside. The average analyst target of $316.86 implies only 2.6% upside, and the stock trades at a 23% premium to the sector P/E. However, the company's accelerating revenue growth (8.5% YoY) and superior net margin (17.4%) provide a solid foundation. The biggest downside risk is a cyclical downturn, which could push the stock to $260, a -15.8% decline. For long-term investors, NDSN is a reasonable buy on any pullback below $280, while short-term traders may find limited upside.
NDSN is better suited for long-term investment, given its stable growth, strong cash flow, and dividend yield of 1.36%. The stock's beta of 0.96 indicates moderate volatility, but its 42.1% gain over the past year shows strong momentum. Short-term trading could be profitable given the uptrend, but the limited upside to analyst targets suggests a pullback risk. For long-term investors, a minimum holding period of 3-5 years is recommended to ride out cyclical fluctuations and benefit from the company's compounding growth. The stock is not ideal for income investors seeking high yields, but it offers a balanced risk-reward profile.